Sophie Nicolich-Henkin

Sophie Nicolich-Henkin

Auto-generated profile, based on publicly available information

Sophie Nicolich-Henkin

Division of Endocrinology, NYU Long Island School of Medicine , Mineola, NY 11501, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2025 in JCEM Case Reports
Verified
Journal Article
Open access
SNSophie Nicolich-Henkin
Sophie Nicolich-Henkin
LWLauren Waters
Lauren Waters
NBNeha Bansal
Neha Bansal
SKStanislaw Klek
Stanislaw Klek
Capiversatib is a pan-Ak strain transforming inhibitor used in combination with fulvestrant for the treatment of hormone receptor-positive advanced breast cancer and has a known adverse effect of hyperglycemia. We present 3 cases of severe hyperglycemia, 2 of which presented as diabetic ketoacidosis, in patients being treated with capivasertib. These cases demonstrate the severity of hyperglycemia that can result from capivasertib use, as well as highlight treatment regimens and patient outcomes.

15 December 2023 in JCEM Case Reports
Verified
Journal Article
Open access
PDF file
SNSophie Nicolich-Henkin
Sophie Nicolich-Henkin
MGMichael B Goldstein
Michael B Goldstein
EREmma Roellke
Emma Roellke
JBJohn P Bilezikian
John P Bilezikian
GRGary D Rothberger
Gary D Rothberger
Parathyroid adenoma (PA) and parathyroid hyperplasia (PH) are common causes of primary hyperparathyroidism (PHPT), for which the only definitive treatment is surgery. Abnormalities in the parathyroid glands can be identified with various imaging modalities including ultrasound (US), sestamibi scan (MIBI), 4-dimensional computed tomography (4D-CT), and positron emission tomography/computed tomography (PET/CT). While it is not uncommon for parathyroid pathology to be undetected on imaging, this is more typical of low-volume hyperplasia and smaller-sized adenomas. We present the case of a 65-year-old man with PHPT who initially had a solitary parathyroid mass detected by US, but who was ultimately discovered to have massive PH with hyperplastic glands not visualized on US or MIBI. This atypical presentation may help guide providers in decisions on ordering and interpreting various imaging modalities for patients with PHPT. In this case, 4D-CT was the only modality in which large hyperplastic glands were identified, suggesting superior sensitivity. This case also highlights the importance of intraoperative parathyroid hormone testing to aid in diagnostic prediction.